The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Activated protein C resistance (FVLeiden) and thrombosis: factor V mutations causing hypercoagulable states

På svenska

Author

Summary, in English

The integrity of the vascular system is of prime importance for survival. Therefore, several emergency and repair systems safeguard the circulatory system. Multiple processes jointly limit vascular damage and blood loss. In this article, the authors focus on the protein C anticoagulant pathway and the role of activated protein C resistance in thrombotic disease, and they discuss the involvement in thrombosis of mutations other than the Arg506Gln mutation in the gene encoding for factor V.

Publishing year

2003

Language

English

Pages

37-37

Publication/Series

Hematology/Oncology Clinics of North America

Volume

17

Issue

1

Document type

Journal article review

Publisher

W.B. Saunders

Topic

  • Clinical Medicine

Status

Published

Research group

  • Clinical Chemistry, Malmö

ISBN/ISSN/Other

  • ISSN: 0889-8588